About Us
Leading Innovation in Animal HealthMictamid® manufactured by Contura Vet® (USA) Inc.
At Contura Vet®, our mission is to provide innovative hydrogel-based solutions that improve the quality of life for animals with chronic conditions.
We are committed to transforming the lives of animals and their owners through groundbreaking technology and innovative solutions. Our mission is to deliver safe, effective, and sustainable treatments that enhance the well-being and performance of animals worldwide.
Our hydrogel platform is built on:
Biocompatible
Rigorously tested to surpass strict industry requirements, securing global approvals that set new industry benchmarks
Bio-integrated
Unlike other injectables, 2.5% iPAAG is non-degradable and fully integrates with surrounding tissue
Providing significant benefit
We will only enter markets where we believe 2.5% iPAAG addresses a significant clinical need and can offer clinically-meaningful results
Clinically proven
We maintain 2.5% iPAAG’s market-leading efficacy and safety profile by conducting robust clinical research for each of the therapeutic areas we enter
Manufactured in our state-of-the-art facility
We maintain 2.5% iPAAG’s market-leading efficacy and safety profile by conducting robust clinical research for each of the therapeutic areas we enter
Discover how Mictamid® supports long-term durability and symptom improvements for incontinence.
Discover how targeted urethral support can make a measurable difference.